Comprehensive HPV Vaccination for Men and Women Aged 9 – 24 Years

It is estimated that nearly all sexually active individuals will contract HPV at least once in their lifetime, most commonly between the ages of 16 and 25. Approximately 10–20% of women may develop persistent HPV infection, which can progress to precancerous cervical lesions and eventually cervical cancer over a period of 20–25 years.

HPV is primarily transmitted through skin-to-skin contact in the genital area, including vaginal, oral, and anal intercourse. While condoms, when used correctly, can reduce the risk of sexually transmitted infections, they do not offer complete protection against HPV since the virus can infect areas not covered by condoms.

The introduction of the HPV vaccine marked a breakthrough in cancer prevention – reducing the risk of cervical cancer caused by high-risk HPV strains by over 90%, and significantly lowering the rates of precancerous lesions and HPV-related diseases in both men and women.

The earlier the HPV vaccination, the stronger the protection — ideally before the onset of sexual activity.

Current Types of HPV Vaccines

There are currently six HPV vaccines in use worldwide. Among them, Gardasil® 9 is one of the most advanced vaccines for HPV prevention:

• Gardasil® 9 – protects against 9 HPV types (6, 11, 16, 18, 31, 33, 45, 52, and 58). Developed by MSD (Merck & Co., USA), one of the world’s leading pharmaceutical companies, and first approved by the U.S. FDA in 2014.
• Gardasil® / Cervavac – protects against 4 HPV types (6, 11, 16, 18).
• Cervarix® / Walrinvax / Cecolin – protects against 2 high-risk HPV types (16, 18).

All HPV vaccines have been proven safe and effective, and are recommended by the U.S. FDA.

Who Should Get the HPV Vaccine and When?

• Children (both boys and girls) aged 9–14 years: Two-dose schedule (at least 6 months apart) or a three-dose regimen. This is the optimal age range for maximum protection.
• Adolescents and adults aged 15–24 years: Three-dose schedule: the second dose given 1–2 months after the first, and the third dose 6 months after the first.
• Individuals with weakened immune systems: Should receive three doses regardless of age.
• Those who are sexually active: Even if sexually active, vaccination remains beneficial. It can protect against high-risk HPV types not yet contracted, and reduce the risk of reinfection or progression of HPV-related conditions.

Note: Vaccination does not replace routine cervical cancer screening. Women should continue regular Pap smears and HPV testing starting at age 21, as recommended by healthcare providers.

————–

Hanoi French Hospital (HFH) is a trusted provider for HPV vaccination and comprehensive gynecological care, offering:

• A team of experienced Obstetricians-Gynecologists collaborating with Pediatricians (for patients under 16) who conduct thorough examinations before each vaccination. HFH doctors are internationally trained and provide professional, evidence-based guidance for optimal protection.
• Vaccines sourced exclusively from official distributors, stored and handled under Good Storage Practice (GSP) standards using state-of-the-art equipment to ensure quality and safety.
• Post-vaccination monitoring and care instructions following the latest recommendations from the World Health Organization (WHO).
• A modern medical facility equipped to respond promptly and safely to any emergency situation.

For detailed consultation, please contact our Hotline: 024.3577.1100, inbox our Fanpage “Hanoi French Hospital”, or reach us via Zalo OA: zalo.me/2008009049335817955